Abstract:Sustained stress leads to series of changes in the brain, firstly through the activation of hypothalamus–pituitary–adrenal (HPA) axis and sympathetic nervous system (SNS) axis, then the release of glucocorticoid (GCs) and catecholamines (CAs), respectively. The circulating GCs can cause neuronal injury and even the loss of neurons, accompanying the increased level of proinflammatory cytokines in the circulation. Chronic stress has been linked to various diseases, especially mood disorders and neuropsychiatric disorders, mainly mediated by the limbic system. Yet the relationship between chronic stress and neurodegenerative disorders such as Alzheimer disease (AD) and Parkinson’s disease (PD) is unknown. It has been found that depression often precedes PD symptoms in clinical subjects [1], while many PD patients present with depression symptoms as well [2,3]. A recent study published in Molecular Psychiatry by Hemmerle et al. [4] addressed this point by subjecting 6-OHDA-lesioned rats to the chronic stress, and they found that chronic stress exacerbates the loss of dopamine neurons induced by 6-OHDA injection. The results strongly argued that chronic stress may function as an important factor in the development of PD and potentially other neurodegenerative diseases. Hemmerle et al. generated a rat model of PD by unilateral 6-OHDA injection, which produces selective toxicity to dopamine neurons, especially in substantia nigra. The dopamine neuron loss leads to motor behavior deficits, as reflected by the forelimb asymmetry test, because the loss of dopamine neurons would lead to impaired usage of the contralateral limb, while the severity of dopamine neuron loss was histologically examined by TH staining [4]. When the rats were subjected to chronic unpredictable stress, the authors found that the rats would demonstrate increased forelimb asymmetry (suggestive of worse behavior), which correlated with increased dopamine neuron loss (decreased TH staining). Interestingly, the chronic stress alone did not induce loss of dopamine neurons, and the stress had to occur simultaneously with toxin exposure [4], suggesting that the stress might act adjuvantly with the toxin or increase the vulnerability of the neurons. In clinical studies, depression as the most common disease caused by chronic stress may occur prior to PD symptoms [1] and may indicate worse prognosis for PD patients [5]. Yet it should be noted that the loss of dopamine neurons could occur much earlier to the motor symptoms [6] and therefore may be concurrent with the depression as well. What are the potential mechanisms linking stress and increased dopamine neuron loss? It is possible that glucocorticoid contributes to this process, partly through the glucocorticoid receptors (GRs) on the microglia, because MPTP-induced neurotoxicity was less in mice whose GRs were knocked down selectively on microglial cells [7]. In addition, GRs on dopamine neurons regulate the activity of the cells and might sensitize the neurons through excitotoxicity [8]. On the other hand, there is evidence suggesting that the depression can be caused by loss of dopaminergic innervation during PD progression [2], acting as the downstream of PD pathology. It is believed that the mesolimbic and mesocortical dopaminergic pathways that are disrupted in PD would contribute to the depression symptoms [3]. Indeed, a recent study has shown that selective activation of midbrain dopamine neurons with optogenetic tech-

Influences of Chronic Mild Stress Exposure on Motor, Non-Motor Impairments and Neurochemical Variables in Specific Brain Areas of MPTP/Probenecid Induced Neurotoxicity in Mice

MPTP-Induced Impairment of Cardiovascular Function

Chronic mild stress accelerates the progression of Parkinson's disease in A53T α-synuclein transgenic mice

Neuroprotective Effects of Stemazole in the Mptp-Induced Acute Model of Parkinson'S Disease: Involvement of the Dopamine System

Depression Induced by Chronic Unpredictable Mild Stress Increases Susceptibility to Parkinson’s Disease in Mice Via Neuroinflammation Mediated by P2X7 Receptor

Effects of stress and charpone gene knock-out on neurological fuction in mice with mptp-induced Parkinson's disease

Chronic Stress and Parkinson's Disease

Transcranial Direct Current Stimulation Ameliorates Behavioral Deficits and Reduces Oxidative Stress in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Mouse Model of Parkinson'S Disease

Biochemical, behavioral and immunohistochemical alterations in MPTP-treated mouse model of Parkinson's disease

Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease

Molecular Regulatory Mechanism and Toxicology of Neurodegenerative Processes in MPTP/Probenecid-Induced Progressive Parkinson’s Disease Mice Model Revealed by Transcriptome

Reassessment of subacute MPTP-treated mice as animal model of Parkinson's disease

Behavioral phenotyping of the MPTP mouse model of Parkinson's disease

Enhancement of ATP production ameliorates motor and cognitive impairments in a mouse model of MPTP-induced Parkinson's disease.

Brain Selective Estrogen Treatment Protects Dopaminergic Neurons and Preserves Behavioral Function in MPTP-induced Mouse Model of Parkinson’s Disease

Hippocampal Damage and White Matter Lesions Contribute to Cognitive Impairment in MPTP-lesioned Mice with Chronic Cerebral Hypoperfusion.

Effects of repeated systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to mice on interleukin-1beta and nerve growth factor in the striatum.

Damage to the Nigrostriatal System in the Mptp-Treated Samp8 Mouse

Proteome Analysis of Substantia Nigra and Striatal Tissue in the Mouse MPTP Model of Parkinson's Disease

MPP+-Lesioned Mice: an Experimental Model of Motor, Emotional, Memory/Learning, and Striatal Neurochemical Dysfunctions

The ultrastructural and proteomic analysis of mitochondria‐associated endoplasmic reticulum membrane in the midbrain of a Parkinson's disease mouse model